CLEC-2 activates Syk through dimerization
Open Access
- 8 April 2010
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 115 (14) , 2947-2955
Abstract
The C-type lectin receptor CLEC-2 activates platelets through Src and Syk tyrosine kinases, leading to tyrosine phosphorylation of downstream adapter proteins and effector enzymes, including phospholipase-C γ2. Signaling is initiated through phosphorylation of a single conserved tyrosine located in a YxxL sequence in the CLEC-2 cytosolic tail. The signaling pathway used by CLEC-2 shares many similarities with that used by receptors that have 1 or more copies of an immunoreceptor tyrosine-based activation motif, defined by the sequence Yxx(L/I)x6-12Yxx(L/I), in their cytosolic tails or associated receptor chains. Phosphorylation of the conserved immunoreceptor tyrosine-based activation motif tyrosines promotes Syk binding and activation through binding of the Syk tandem SH2 domains. In this report, we present evidence using peptide pull-down studies, surface plasmon resonance, quantitative Western blotting, tryptophan fluorescence measurements, and competition experiments that Syk activation by CLEC-2 is mediated by the cross-linking through the tandem SH2 domains with a stoichiometry of 2:1. In support of this model, cross-linking and electron microscopy demonstrate that CLEC-2 is present as a dimer in resting platelets and converted to larger complexes on activation. This is a unique mode of activation of Syk by a single YxxL-containing receptor.Keywords
This publication has 34 references indexed in Scilit:
- CLEC-2 Is a Phagocytic Activation Receptor Expressed on Murine Peripheral Blood NeutrophilsThe Journal of Immunology, 2009
- Phospholipase Cγ2 Is Critical for Dectin-1-mediated Ca2+ Flux and Cytokine Production in Dendritic CellsJournal of Biological Chemistry, 2009
- G6b-B Inhibits Constitutive and Agonist-induced Signaling by Glycoprotein VI and CLEC-2Journal of Biological Chemistry, 2008
- Differential Roles of the PKC Novel Isoforms, PKCδ and PKCε, in Mouse and Human PlateletsPLOS ONE, 2008
- Crystal structure of rhodocytin, a ligand for the platelet‐activating receptor CLEC‐2Protein Science, 2008
- CLEC9A Is a Novel Activation C-type Lectin-like Receptor Expressed on BDCA3+ Dendritic Cells and a Subset of MonocytesJournal of Biological Chemistry, 2008
- Renal cells activate the platelet receptor CLEC-2 through podoplaninBiochemical Journal, 2008
- The C-type Lectin Receptors CLEC-2 and Dectin-1, but Not DC-SIGN, Signal via a Novel YXXL-dependent Signaling CascadeJournal of Biological Chemistry, 2007
- The many faces of ITAMsTrends in Immunology, 2007
- The Clearance Mechanism of Chilled Blood PlateletsCell, 2003